Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines

Author： Zhang Jianfeng  

Publisher： MDPI

E-ISSN： 1999-4915|4|11|2711-2735

ISSN： 1999-4915

Source： Viruses, Vol.4, Iss.11, 2012-11, pp. : 2711-2735

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Live-Attenuated Influenza Vaccines against Outbreaks of H5N1 Influenza

By Zheng Dan   Yi Yinglei   Chen Ze  

Viruses, Vol. 4, Iss. 12, 2012-12 ,pp. : 3589-3605

MDPI

Access to resources Recommend Favorite

Virus-Vectored Influenza Virus Vaccines

By Tripp Ralph A.   Tompkins S. Mark  

Viruses, Vol. 6, Iss. 8, 2014-08 ,pp. : 3055-3079

MDPI

Access to resources Recommend Favorite

Innate Immunity to H5N1 Influenza Viruses in Humans

By Ramos Irene   Fernandez-Sesma Ana  

Viruses, Vol. 4, Iss. 12, 2012-11 ,pp. : 3363-3388

MDPI

Access to resources Recommend Favorite

Pandemic Influenza Vaccines – The Challenges

By Haaheim Lars R.   Madhun Abdullah S.   Cox Rebecca  

Viruses, Vol. 1, Iss. 3, 2009-12 ,pp. : 1089-1109

MDPI

Access to resources Recommend Favorite

Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults

By Chichester Jessica A.   Jones R. Mark   Green Brian J.   Stow Mark   Miao Fudu   Moonsammy George   Streatfield Stephen J.   Yusibov Vidadi  

Viruses, Vol. 4, Iss. 11, 2012-11 ,pp. : 3227-3244

MDPI

Access to resources Recommend Favorite